BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 14614028)

  • 1. Inhibition of cyclooxygenase-2 indirectly potentiates antitumor effects of photodynamic therapy in mice.
    Makowski M; Grzela T; Niderla J; ŁAzarczyk M; Mróz P; Kopeé M; Legat M; Strusińska K; Koziak K; Nowis D; Mrówka P; Wasik M; Jakóbisiak M; Gołab J
    Clin Cancer Res; 2003 Nov; 9(14):5417-22. PubMed ID: 14614028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2 inhibitor treatment enhances photodynamic therapy-mediated tumor response.
    Ferrario A; Von Tiehl K; Wong S; Luna M; Gomer CJ
    Cancer Res; 2002 Jul; 62(14):3956-61. PubMed ID: 12124326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
    Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
    Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors.
    Ferrario A; Fisher AM; Rucker N; Gomer CJ
    Cancer Res; 2005 Oct; 65(20):9473-8. PubMed ID: 16230411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2 is a possible target of treatment approach in conjunction with photodynamic therapy for various disorders in skin and oral cavity.
    Akita Y; Kozaki K; Nakagawa A; Saito T; Ito S; Tamada Y; Fujiwara S; Nishikawa N; Uchida K; Yoshikawa K; Noguchi T; Miyaishi O; Shimozato K; Saga S; Matsumoto Y
    Br J Dermatol; 2004 Aug; 151(2):472-80. PubMed ID: 15327557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2.
    Pyo H; Choy H; Amorino GP; Kim JS; Cao Q; Hercules SK; DuBois RN
    Clin Cancer Res; 2001 Oct; 7(10):2998-3005. PubMed ID: 11595687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models.
    Zhou Q; Olivo M; Lye KY; Moore S; Sharma A; Chowbay B
    Cancer Chemother Pharmacol; 2005 Dec; 56(6):569-77. PubMed ID: 16001166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model.
    Nishikawa M; Stapleton PP; Freeman TA; Gaughan JP; Matsuda T; Daly JM
    J Am Coll Surg; 2004 Sep; 199(3):428-35. PubMed ID: 15325613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
    Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J
    Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2 expression induced by photofrin photodynamic therapy involves the p38 MAPK pathway.
    Luna M; Wong S; Ferrario A; Gomer CJ
    Photochem Photobiol; 2008; 84(2):509-14. PubMed ID: 18282182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic therapy: combined modality approaches targeting the tumor microenvironment.
    Gomer CJ; Ferrario A; Luna M; Rucker N; Wong S
    Lasers Surg Med; 2006 Jun; 38(5):516-21. PubMed ID: 16607618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of poor survival by cyclooxygenase-2 in patients with T4 nasopharyngeal cancer treated by radiation therapy: clinical and in vitro studies.
    Chen WC; McBride WH; Chen SM; Lee KF; Hwang TZ; Jung SM; Shau H; Liao SK; Hong JH; Chen MF
    Head Neck; 2005 Jun; 27(6):503-12. PubMed ID: 15772955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study].
    Zhang YC; Wang S; Zhang H; Ye YJ; Liang B; Cui ZR
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):583-6. PubMed ID: 15144595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of photodynamic therapy by 2,5-dimethyl celecoxib, a non-cyclooxygenase-2 inhibitor analog of celecoxib.
    Ferrario A; Lim S; Xu F; Luna M; Gaffney KJ; Petasis NA; Schönthal AH; Gomer CJ
    Cancer Lett; 2011 May; 304(1):33-40. PubMed ID: 21339042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of cyclooxygenase-2 inhibition to enhance the efficacy of immunotherapy.
    DeLong P; Tanaka T; Kruklitis R; Henry AC; Kapoor V; Kaiser LR; Sterman DH; Albelda SM
    Cancer Res; 2003 Nov; 63(22):7845-52. PubMed ID: 14633712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer.
    Kundu N; Fulton AM
    Cancer Res; 2002 Apr; 62(8):2343-6. PubMed ID: 11956094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
    Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
    Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic and naturally occurring COX-2 inhibitors suppress proliferation in a human oesophageal adenocarcinoma cell line (OE33) by inducing apoptosis and cell cycle arrest.
    Cheong E; Ivory K; Doleman J; Parker ML; Rhodes M; Johnson IT
    Carcinogenesis; 2004 Oct; 25(10):1945-52. PubMed ID: 15155531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
    Sengupta S; Sellers LA; Cindrova T; Skepper J; Gherardi E; Sasisekharan R; Fan TP
    Cancer Res; 2003 Dec; 63(23):8351-9. PubMed ID: 14678996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of p53 or p27 overexpression on cyclooxygenase-2 gene expression in head and neck squamous cell carcinoma cell lines.
    Lee DW; Park SW; Park SY; Heo DS; Kim KH; Sung MW
    Head Neck; 2004 Aug; 26(8):706-15. PubMed ID: 15287038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.